RSV Immunoprophylaxis in Infants and Children: Old Standards, New Agents and the Complexities Therein [0.03%]
婴儿和儿童呼吸道合胞病毒免疫预防：旧标准、新制剂及其中的复杂性
Bosco A Paes,Paolo Manzoni,John R Fullarton et al.
Bosco A Paes et al.
Every year, respiratory syncytial virus (RSV) causes an estimated 33 million lower respiratory tract infections in children under five years of age, driving millions of hospitalizations worldwide and substantial mortality in developing coun...
Shifting Attitudes from Willingness to Uptake in COVID-19 and Influenza Vaccination-Associated Factors and Reported Reasons [0.03%]
从愿意接种到实际接种新冠肺炎和流感疫苗的态度转变——相关因素及报告理由
Sara Moura,António Teixeira Rodrigues,Sónia Romano et al.
Sara Moura et al.
Background/objectives: Vaccine hesitancy is a complex and growing phenomenon worldwide, posing a serious threat to public health achievement in disease control and prevention. This study aimed to assess willingness to upt...
Getting the Hepatitis B Birth Dose Vaccine to Every Baby: A Rapid Scoping Review of Birth Dose Vaccine Delivery Strategies in Out-of-Facility Settings [0.03%]
让每一名婴儿都能接种乙肝出生剂量疫苗：设施外场地乙肝出生剂量疫苗交付策略的快速综述研究
Sophia Knudson,Ankita Meghani,Katharine D Shelley et al.
Sophia Knudson et al.
Background/objectives: Globally, coverage of the hepatitis B vaccine within 24 h of birth is 45 percent, far below the WHO target of 90 percent by 2030. For newborns delivered in out-of-facility settings, delayed contact ...
Real-World Safety of Concurrent Measles-Mumps-Rubella and Varicella Vaccination in Korean Infants: A Multicenter Self-Controlled Case Series Study [0.03%]
韩国婴儿联合卡介苗和麻腮风疫苗的现实世界安全性研究：多中心自我作为案例系列研究
Sujin Choi,Bin Ahn,Yeonjoo Lee et al.
Sujin Choi et al.
Background: Measles, mumps, rubella (MMR) and varicella vaccines are often co-administered to optimize coverage, yet safety concerns regarding febrile convulsions persist. In South Korea, MMR and varicella vaccines are ad...
Vaccine Literacy and Social-Cognitive Determinants of Vaccination: Lessons from a Special Issue and Future Directions [0.03%]
疫苗知识及接种的社会认知决定因素：一个专题的启示与未来方向
Chiara Lorini,Vieri Lastrucci
Chiara Lorini
Vaccination remains one of the most effective public health interventions for preventing infectious diseases, reducing morbidity and mortality, and protecting communities across the life course [...].
Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. Vaccines 2025, 13, 1169 [0.03%]
correction: fukushima等人.日本成人旅行者狂犬病暴露前预防的长期免疫原性：剂量方案的比较。Vaccines 2025, 13, 1169
Shinji Fukushima,Akira Nishizono,Takehiro Hashimoto et al.
Shinji Fukushima et al.
The authors would like to make the following corrections to this published paper [...].
Published Erratum
Vaccines. 2026 May 26;14(6):472. DOI:10.3390/vaccines14060472 2026
Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review [0.03%]
欧盟、欧洲经济区、瑞士和英国移民周期中寻求庇护者、难民和无证移民的疫苗接种情况：系统评价
Saleh Aljadeeah,Anil Babu Payedimarri,Carine Dochez et al.
Saleh Aljadeeah et al.
Introduction: Inequities in access to medicines persist for asylum seekers, refugees, and undocumented migrants in Europe. For vaccines, access gaps not only exist for these groups in childhood routine immunization, but also for life-course...
Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies [0.03%]
人呼吸道合胞病毒中和抗体检测方法研究进展
Qi Shen,Jing Gai,Yanqiu Zhou
Qi Shen
Human respiratory syncytial virus (HRSV) is a major cause of severe lower respiratory tract infections in infants, young children, and older adults worldwide. With the approval of nirsevimab and HRSV vaccines, accurate measurement of neutra...
Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025) [0.03%]
世卫组织非洲区域25年的麻疹和麻疹风疹疫苗接种运动经验（2001-2025）
Balcha Girma Masresha,Goitom Gebremedhin Weldegebriel,Emmaculate Jepkorir Lebo et al.
Balcha Girma Masresha et al.
Introduction: The WHO African Region is working to eliminate measles and rubella in 80% of countries by 2030. In countries with sub-optimal routine immunization coverage, periodic supplemental Immunization Activities (SIA...
Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025 [0.03%]
中国安徽省2016—2025年度流感疫苗上市后安全性监测
Fanya Meng,Sicheng Wei,Binbing Wang et al.
Fanya Meng et al.
Background: China's influenza vaccine (InfV) has undergone multiple iterations and numerous technological breakthroughs, providing tremendous impetus and solid support for the development of China's health sector. As the number of vaccinate...